Mustang Bio (MBIO) Price to Sales (2018)
Mustang Bio's (MBIO) quarterly Price to Sales came in at 285565.34 in Q1 2018.
Powered by 
Analysis
Mustang Bio (MBIO) Price to Sales (2018) Analysis & Trends
Mustang Bio (MBIO) has reported Price to Sales for 1 consecutive years, with 285565.34 the latest figure, recorded in Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.66 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.15 Bn | 1.36 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Mustang Bio | 3.53 Mn | 3.53 Mn | - |